USPTO serial 87598480
LIVINGSTONE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 2, 2019
- Examiner
- SINGLETON, RUDY
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with LIVINGSTONE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Drayson Technologies (Europe) Limited
London W10 5AD, GB
Other trademarks owned by Drayson Technologies (Europe) Limited
ROATH, CARDIFF, WALES, GB
OXFORD OX4 4GE, GB
OXFORD OX4 4GE, GB
OXFORD OX4 4GE, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jason Aquilino
Jason Aquilino AQUILINO LAW LLC1635 Old 41 HwySte 112-225Kennesaw, GA 30152Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Artificial intelligence systems comprised of computers, computer operating software and software for the analysis of data from environmental, life sciences, including pharmaceutical, biotechnology and medical devices, and healthcare fields; software, application software, interface software, downloadable software and downloadable computer software platforms for the analysis of data using artificial intelligence from the environmental, life sciences, including pharmaceutical, biotechnology and medical devices, and healthcare fields; data mining software for use in connection with pharmaceutical drug discovery, drug development, chemogenomics, toxicogenomics and drug response prediction; computer modelling and analysis software, namely, software for the analysis of data from environmental, life sciences, including pharmaceutical, biotechnology and medical devices, and healthcare fields; computer software for accessing, viewing and processing patient medical information for use in the healthcare field; computer software for measuring air pollution; computer software for measuring the presence of electromagnetic radiation; computer software for downloading, uploading, accessing, posting, displaying, tagging, streaming, linking, sharing and providing electronic media and accessing information from databases via computer and communications networks; software downloadable from the internet for downloading, uploading, accessing, posting, displaying, tagging, streaming, linking, sharing and providing electronic media and accessing information from databases via computer and communications networks; development tools for computer and internet software; computer software for use as an application programming interface; computer software applications for the development of digital virtual agents, predictive systems, cognitive process automation, visual computing applications, knowledge virtualisation, robotics and drones; software applications enabling machine learning, natural language processing, genetic and deep learning algorithms, semantic ontologies, pattern recognition and knowledge modelling technologies; computer applications that provide solutions for cognitive enhancement in respect of experience and productivity, accelerating processes, automation and autonomy | ACTIVE | — |
| 042 | Industrial analysis, namely, the analysis of data from environmental, life sciences, including pharmaceutical, biotechnology and medical devices, and healthcare fields and research services in the field of environmental, life sciences, including pharmaceutical, biotechnology and medical devices, and healthcare; design and development of computer hardware and software; software as a service, namely, for database mining, database analysis, database management, communication of data and the application of artificial intelligence; data mining services; the provision of computer software as a service, featuring software for pharmaceutical drug discovery, drug development, chemogenomics, toxicogenomics and drug response prediction; the provision of data as a service; the provision of a network platform as a service (PAAS) featuring computer software platforms for database mining, database analysis, database management and the application of artificial intelligence; the provision of a network and database management platform as a service (PAAS) featuring software for database mining, database analysis, database management and the application of artificial intelligence; hosting of digital content offline and online on the internet; environmental science research and technical consultancy information in the field of environmental science, consultancy and advisory services for all the aforesaid services; development and testing of computing methods, algorithms and software; development and testing of computing methods, algorithms and software in a virtual space; research and consultancy in the fields of artificial intelligence, machine learning, deep learning and reinforcement learning; design, development and analysis of environments for reinforcement learning; providing information on computer technology and programming via a website; development, creation, hosting and administration of internet web sites, computers and online databases, and internet portals; design and development of computer software and internet software; application service provider (ASP), namely, hosting of platforms and databases computer software on the internet for use by others; application service provider (ASP), namely, hosting computer software applications for use by others; the provision of data in the field of environmental, life sciences, including pharmaceutical, biotechnology and medical devices, and healthcare and online non-downloadable data management platforms through a computer network including cloud computing network; the provision of data communications protocols, namely, to facilitate database mining, database analysis, database management, communication of data and the application of artificial intelligence; the provision of network services, namely, to enable collaborative data projects across multiple sites; the provision of computer software as a service featuring computer software for accessing and viewing patient medical information for use in the healthcare field; leasing of software platforms, databases, network electronic equipment and sensors; technical services for providing electronic data via communications networks, namely, for database mining, database analysis, database management, communication of data and the application of artificial intelligence; research and design relating to scientific and technological services, in the field of environmental, life sciences, including pharmaceutical, biotechnology and medical devices, and healthcare; development and implementation of software and technology solutions in the field of environmental, life sciences, including pharmaceutical, biotechnology and medical devices, and healthcare in respect of digital virtual agents, predictive systems, cognitive process automation, visual computing applications, knowledge virtualisation, robotics and drones; development and implementation of software and technology solutions in the field of environmental, life sciences, including pharmaceutical, biotechnology and medical devices, and healthcare which enable machine learning, pattern recognition and knowledge modelling technologies; development and implementation of software and technology solutions in the field of environmental, life sciences, including pharmaceutical, biotechnology and medical devices, and healthcare for self-calibration of sensors and detectors, automation and autonomy; consultancy in relation to the development and implementation of software and software based applications; information, advisory and consultancy services in respect of all of the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Drayson Technologies (Europe) Limited
- Other trademarks owned by PHARMATELLIGENCE LIMITED
- Other trademarks owned by SENSYNE HEALTH GROUP LIMITED
- Other trademarks owned by SENSYNE HEALTH GROUP LIMITED
- Other trademarks owned by SENSYNE HEALTH GROUP LIMITED
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named LIVINGSTONE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 29, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 29, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 1, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 5, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 5, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 5, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 5, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 5, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 5, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 2, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 25, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 2, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 16, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 12, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 11, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 19, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 19, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 12, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 8, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 8, 2019 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 8, 2019 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 8, 2019 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Dec 5, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 9, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 9, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 9, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 18, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 18, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jul 3, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jun 19, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 12, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 9, 2017 | NWAP | NEW APPLICATION ENTERED | — |